White Paper
Redefining OPEX modelling for a competitive future
Oct 31, 2022
Download

Pharma companies invest significant efforts in forecasting drug revenues, but what about operational expenditure (OPEX)?

Leveraging IQVIA's unique launch expertise and data insight, our Strategy Consulting team has developed a robust methodology to benchmark and predict OPEX for early- and late-stage assets. This is giving pharma executives greater confidence in their investment decisions and go-to market plans, and allowing portfolio and brand teams to invest with impact.

This white paper outlines our latest thinking on OPEX, and provides an overview of our modelling methodology and recent project experience.

Contact Us